Latest data from December 30, 2021
Number of Health Center respondents = 16 (100% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 13,752 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 79.40% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 4,001 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 85.53% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)2 | Patients Tested Positive, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 17.61% | 12.70% |
| White, Hispanic/Latino Patients | 17.76% | 17.45% |
| Black/African American, Non-Hispanic/Latino Patients | 20.53% | 24.39% |
| Black/African American, Hispanic/Latino Patients | 2.49% | 1.70% |
| Asian Patients3 | 1.51% | 1.35% |
| American Indian/Alaska Native Patients3 | 0.39% | 0.50% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.75% | 1.60% |
| Patients with More than one race3 | 2.55% | 2.72% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 21.92% | 25.32% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 4.85% | 4.27% |
| Unreported/Refused to Report Race and Ethnicity | 9.64% | 8.00% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 3,110 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 84.25% |
| COVID-19 Immunization Series Completed | 2,364 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 84.62% |
| COVID-19 Immunization Series Additional | 9,409 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 72.50% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 12.06% | 11.84% | 21.21% |
| White, Hispanic/Latino Patients | 17.91% | 18.36% | 15.66% |
| Black/African American, Non-Hispanic/Latino Patients | 12.73% | 11.80% | 10.38% |
| Black/African American, Hispanic/Latino Patients | 1.96% | 1.40% | 1.33% |
| Asian Patients3 | 3.02% | 3.09% | 4.49% |
| American Indian/Alaska Native Patients3 | 0.48% | 0.34% | 0.55% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.39% | 0.42% | 0.26% |
| Patients with More than one race3 | 1.22% | 1.69% | 0.97% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 26.78% | 28.09% | 22.30% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 12.09% | 10.11% | 8.52% |
| Unreported/Refused to Report Race and Ethnicity | 11.35% | 12.86% | 14.34% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 0.00% |
| 1 to 24 Hours | 12.50% |
| More Than 24 Hours | 81.25% |
| N/A | 6.25% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 6.25% |
| Staffing to administer the vaccine | 62.50% |
| Vaccine confidence | 18.75% |
| Vaccine storage capacity | 0.00% |
| Vaccine supply | 12.50% |
| Other | 6.25% |
| None | 18.75% |
Operations and Staff
| Metrics | Value |
|---|---|
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 6.25% |
| Average Percent of Health Center Visits Conducted Virtually | 34.06% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 43.75% |
| Number of Mobile Van Sites | 5 |
| Number of Pop-up Clinics | 66 |
| Number of School-Based Vaccination Sites | 13 |
| Number of Family Vaccination Clinics | 65 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 0.00% |
| Refer patients to another organization that provides monoclonal antibody therapies | 68.75% |
| None | 31.25% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 6.25% |
| Patient awareness/education | 0.00% |
| Staffing capacity | 12.50% |
| Therapy administration/onsite logistics | 25.00% |
| Other | 0.00% |
| None | 68.75% |
Test Kit Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 3 |
| Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 11,350 |
Test Kit Distribution Methods4
| Metrics | Value |
|---|---|
| Provide to Existing Health Center Patients | 100.00% |
| Provide to General Public Who Came to the Health Center | 66.67% |
| Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 33.33% |
| Provide at Other Community Events | 33.33% |
| Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) | 66.67% |
| Other | 33.33% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
